(Q34136829)

English

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. (English)

1 reference

Europe PubMed Central

31 July 2017

Ehlers-Danlos syndrome

0 references

circulatory system

1 reference

based on heuristic

inferred from title

12

object named as

Anne De Paepe

0 references

Xavier Jeunemaitre

14

object named as

Xavier Jeunemaitre

1 reference

Europe PubMed Central

31 July 2017

Julie De Backer

object named as

Julie De Backer

3

0 references

Pierre Boutouyrie

object named as

Pierre Boutouyrie

16

0 references

author name string

Kim-Thanh Ong

1

1 reference

Europe PubMed Central

31 July 2017

Jérôme Perdu

2

1 reference

Europe PubMed Central

31 July 2017

Erwan Bozec

4

1 reference

Europe PubMed Central

31 July 2017

Patrick Collignon

5

1 reference

Europe PubMed Central

31 July 2017

Joseph Emmerich

6

1 reference

Europe PubMed Central

31 July 2017

Anne-Laure Fauret

7

1 reference

Europe PubMed Central

31 July 2017

Jean-Noël Fiessinger

8

1 reference

Europe PubMed Central

31 July 2017

Dominique P Germain

9

1 reference

Europe PubMed Central

31 July 2017

Gabriella Georgesco

10

1 reference

Europe PubMed Central

31 July 2017

Jean-Sebastien Hulot

11

1 reference

Europe PubMed Central

31 July 2017

Henri Plauchu

13

1 reference

Europe PubMed Central

31 July 2017

Stéphane Laurent

15

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

7 September 2010

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

376

1 reference

Europe PubMed Central

31 July 2017

1476-1484

1 reference

Europe PubMed Central

31 July 2017

9751

1 reference

Europe PubMed Central

31 July 2017

Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased carotid wall stress in vascular Ehlers-Danlos syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory complications of Ehlers-Danlos syndrome type IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Marfan syndrome: abnormal aortic elastic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aneurysm syndromes caused by mutations in the TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating transforming growth factor-beta in Marfan syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between cytokine concentrations and wound healing in chronic venous ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic effects of celiprolol in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960960-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60960-9

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34136829&oldid=1965368767"